Trial Profile
Testosterone plus exercise to improve muscle strength and performance in men affected by inclusion body myositis (IBM)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Inclusion body myositis
- Focus Therapeutic Use
- Acronyms TEX-IBM
- Sponsors Lawley Pharmaceuticals
- 11 Mar 2021 Status changed from active, no longer recruiting to completed.
- 30 Jul 2019 Planned End Date changed from 11 Jan 2019 to 31 Jul 2020.
- 30 Jul 2019 Status changed from not yet recruiting to active, no longer recruiting.